T. Makitie et al., COMPARATIVE IMMUNOHISTOCHEMICAL ESTROGEN-RECEPTOR ANALYSIS IN PRIMARYAND METASTATIC UVEAL MELANOMA, Graefe's archive for clinical and experimental ophthalmology, 236(6), 1998, pp. 415-419
Background: The investigation reported here was carried out to determi
ne the oestrogen receptor status of metastatic and primary uveal melan
omas. Methods: A series of 23 primary and 24 metastatic formalin-fixed
, paraffin-embedded choroidal melanomas were analysed immunohistochemi
cally with the monoclonal antibody (MAb) 1D5 using the avidin-biotinyl
ated peroxidase method and antigen retrieval with microwaves. Melanoph
ages were identified with MAb PC-Mi to macrophages. Results: None of t
he primary or metastatic melanomas contained tumour cells that would h
ave shown a nuclear immunoreaction for oestrogen receptors with MAb 1D
5. However, in 20 of the 23 primary tumours and in 14 of the 24 metast
ases a variable number of infiltrating cells showed a strong positive
cytoplasmic immunoreaction with MAb 1D5. The cells contained pigmented
cytoplasmic granules that resisted bleaching of melanin and their cyt
oplasm was strongly labelled with MAb PC-Mi, identifying them as cross
-reacting macrophages. Conclusion: Oestrogen receptors can not be used
as a prognostic indicator if anti-oestrogen therapy is considered for
treatment of metastatic uveal melanoma. However, because anti-oestrog
ens also act by other mechanisms on both tumour and host tissues, the
lack of oestrogen receptors does not automatically negate their therap
eutic effect in disseminated melanoma.